DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Marplan (Isocarboxazid) - Published Studies

 
 



Marplan Related Published Studies

Well-designed clinical trials related to Marplan (Isocarboxazid)

Moclobemide in depression: a randomized, multicentre trial against isocarboxazide and clomipramine emphasizing atypical depression. [1991.12]

A trial of isocarboxazid in the treatment of bulimia nervosa. [1988.12]

An efficacy study of isocarboxazid and placebo in depression, and its relationship to depressive nosology. [1988.02]

Well-designed clinical trials possibly related to Marplan (Isocarboxazid)

Efficacy of antidepressants for dysthymia: a meta-analysis of placebo-controlled randomized trials. [2011]

Efficacy of antidepressants and benzodiazepines in minor depression: systematic review and meta-analysis. [2011]

Antidepressants versus placebo for people with bulimia nervosa. [2001]

The Major Depression Rating Scale (MDS). Inter-rater reliability and validity across different settings in randomized moclobemide trials. Danish University Antidepressant Group. [1997.01]

Effectiveness of piracetam in cortical myoclonus. [1993]

Other research related to Marplan (Isocarboxazid)

[Prolonged hyperthermia after isocarboxazid poisoning] [2003.04.28]

Disruption of FR-40 by 5-HT agonists. II. Effects of chronic phenelzine or isocarboxazid. [1989.10]

The response of depressed inpatients to isocarboxazid. [1988.04]

Other possibly related research studies

Translating the evidence on atypical depression into clinical practice. [2007]

Antidepressants versus placebo for people with bulimia nervosa. [2003]

Body weight changes associated with psychopharmacology. [2002.07]

A 3-year follow-up of a group of treatment-resistant depressed patients with a MAOI/tricyclic combination. [1995.06.08]

MAOIs in the contemporary treatment of depression. [1995.05]

Serotonin syndrome. [1995.02]

The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors. [1995.02]

Recent pharmacologic advances in antidepressant therapy for the elderly. [1993.05.24]

Monoamine oxidase inhibitors and elective surgery. [1993.03]

Suicide and fatal antidepressant poisoning. [1992.10]

Influence of higher rates of agitation on release patterns of immediate-release drug products. [1992.06]

Central nervous system toxicity after abrupt monoamine oxidase inhibitor switch: a case report. [1992.03]

Pathologic hair-pulling: a review of the literature and case reports. [1992.03]

Predictors of response to monoamine oxidase inhibitors: do they exist? [1991]

Anorexia nervosa in the elderly: a case report and review of the literature. [1990.12]

Inhibited female orgasm resulting from psychotropic drugs. A five-year, updated, clinical review. [1990.01]

Efficacy of combined antidepressant therapy in resistant neurotic disorder. [1990.01]

Classification of depression by grade of membership: a confirmation study. [1989.11]

Symptoms of interpersonal sensitivity in depression. [1989.09]

Neuroleptic malignant syndrome: a case report with post-mortem brain and muscle pathology. [1989.08]

Severe daytime somnolence in patients treated with an MAOI. [1988.12]

Monoamine oxidase inhibitors and weight gain. [1988.10]

MAOI treatment response: multiaxial assessment. [1988.03]

A comparative evaluation of three discriminant scales for endogenous depression. [1988.02]

[Irreversible, non-selective monoamine oxidase inhibitors] [2009.04.16]

Efficacy of antidepressants for dysthymia: a meta-analysis of placebo-controlled randomized trials. [2011.04]

Efficacy of antidepressants and benzodiazepines in minor depression: systematic review and meta-analysis. [2011.01]

The cannabinergic system is implicated in the upregulation of central NGF protein by psychotropic drugs. [2011.05]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017